
Kala azar

Diagnosing, treating and researching HIV-kala azar co-infection in Ethiopia

Five epidemics to watch

Tackling a deadly outbreak of tropical disease

Increased access to diagnosis and treatment of HIV-VL co-infection is imperative for eliminating kala azar

MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State
Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)
Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh - A Case Report

Better detection, diagnosis and treatment needed for neglected complication of kala azar in Bihar

Access to kala azar treatment in public healthcare system needs to be scaled up
Clinical Epidemiology, Diagnosis and Treatment of Visceral Leishmaniasis in the Pokot Endemic Area of Uganda and Kenya
Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

MSF Field Research
We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.
Visit site